These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 17928772
21. Study design and baseline characteristics of patients in the PRESENT study. Shestakova M, Bech OM, Momani MS. Diabetes Res Clin Pract; 2008 Sep; 81 Suppl 1():S3-9. PubMed ID: 18672309 [Abstract] [Full Text] [Related]
22. Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus. Guo LX, Pan Q, Wang XX, Li H, Zhang LN, Chi JM, Wang Y. Chin Med J (Engl); 2008 Apr 20; 121(8):687-90. PubMed ID: 18701019 [Abstract] [Full Text] [Related]
23. Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE study. Yenigun M, Honka M. Int J Clin Pract; 2009 Mar 20; 63(3):425-32. PubMed ID: 19222627 [Abstract] [Full Text] [Related]
24. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)]. Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T. Dtsch Med Wochenschr; 2009 Jun 20; 134(23):1207-13. PubMed ID: 19472091 [Abstract] [Full Text] [Related]
25. Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988-2004. Suh DC, Kim CM, Choi IS, Plauschinat CA, Barone JA. J Hypertens; 2009 Sep 20; 27(9):1908-16. PubMed ID: 19491704 [Abstract] [Full Text] [Related]
26. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus. Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R. Patient Educ Couns; 2008 Oct 20; 73(1):50-9. PubMed ID: 18583087 [Abstract] [Full Text] [Related]
27. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Bakiner O, Ertorer ME, Bozkirli E, Tutuncu NB, Demirag NG. Acta Diabetol; 2009 Mar 20; 46(1):63-5. PubMed ID: 18825302 [Abstract] [Full Text] [Related]
28. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Diabetes Res Clin Pract; 2008 Oct 20; 82(1):139-47. PubMed ID: 18703252 [Abstract] [Full Text] [Related]
29. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group. Diabetes Obes Metab; 2008 Mar 20; 10(3):212-22. PubMed ID: 18269636 [Abstract] [Full Text] [Related]
30. Severe insulin allergy after percutaneous transluminal coronary angioplasty. Wang C, Ding ZY, Shu SQ, Liu Y, Chen YC, Ran XW, An ZM, Tian HM, Tong NW, Li XJ, Yu YR. Clin Ther; 2009 Mar 20; 31(3):569-74. PubMed ID: 19393846 [Abstract] [Full Text] [Related]
31. Initiating insulin in patients with type 2 diabetes. Aoki TJ, White RD. J Fam Pract; 2007 Aug 20; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139 [Abstract] [Full Text] [Related]
32. Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study. Lonati C, Morganti A, Comarella L, Mancia G, Zanchetti A, IPERDIA Study Group. J Hypertens; 2008 Sep 20; 26(9):1801-8. PubMed ID: 18698215 [Abstract] [Full Text] [Related]
33. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes. Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS. Exp Clin Endocrinol Diabetes; 2008 May 20; 116(5):282-8. PubMed ID: 18484560 [Abstract] [Full Text] [Related]
34. [Mechanisms for weight gain during blood glucose normalization]. Laville M, Andreelli F. Diabetes Metab; 2000 Jun 20; 26 Suppl 3():42-5. PubMed ID: 10945152 [Abstract] [Full Text] [Related]
35. [Insulin and weight gain: myth or reality?]. Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Diabetes Metab; 2001 Nov 20; 27(5 Pt 3):S23-7. PubMed ID: 11910976 [Abstract] [Full Text] [Related]
36. [How many and who are receiving medication for diabetes mellitus?]. Strøm H, Engeland A, Eriksen E, Sakshaug S, Rønning M. Tidsskr Nor Laegeforen; 2006 Mar 09; 126(6):768-70. PubMed ID: 16541171 [Abstract] [Full Text] [Related]
37. Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Russell-Jones D, Khan R. Diabetes Obes Metab; 2007 Nov 09; 9(6):799-812. PubMed ID: 17924864 [Abstract] [Full Text] [Related]
38. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Ballani P, Tran MT, Navar MD, Davidson MB. Diabetes Care; 2006 Nov 09; 29(11):2504-5. PubMed ID: 17065692 [No Abstract] [Full Text] [Related]
39. Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus. Kuritzky L, Nelson SE. J Fam Pract; 2005 Jun 09; 54(6):S3-6. PubMed ID: 16021782 [No Abstract] [Full Text] [Related]
40. Injection-site skin lesions following pen-injection treatment in a 59-year-old woman with insulin-treated Type 2 diabetes mellitus. Winkler G, Sápi Z, Pál B, Molnár L. Diabet Med; 1997 Dec 09; 14(12):1078-9. PubMed ID: 9455937 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]